8. What is the vision for QuIC-ConCePT?
QuIC-ConCePT aims to qualify imaging biomarkerss of tumor cell proliferation, apoptosis, and necrosis that will allow drug developers to reliably demonstrate the modulation of these pathologic processes in tumors in patients in cancer clinical trials.
“By 2016, drug developers will be able to incorporate these imaging biomarkers in Phase I trials of investigational therapies confident that the imaging biomarkers are:
- technically valid,
- measured change in the imaging biomarkers faithfully reflects the desired change in the underlying tumour pathology,
- can be deployed in multiple cancer centres in a robust, consistent, ethical, and cost-effective way acceptable to patients”.